Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cerebrovascular vulnerability and fibrosis in human brain aneurysms.

Nature neuroscience·2026

Same author

BMP9-mediated regulation of endothelin-1 requires integrated SMAD1/5 and SMAD2/3 signaling.

bioRxiv : the preprint server for biology·2026

Same author

PIEZO1 Overexpression in Hereditary Hemorrhagic Telangiectasia Arteriovenous Malformations.

Circulation·2025

Same author

A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations.

Cardiovascular research·2024

Same author

Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.

Angiogenesis·2023

Same author

BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.

Angiogenesis·2022

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Tnk1/Kos1 knockout mice develop spontaneous tumors.

Sarasija Hoare¹, Kishalay Hoare, Mary K Reinhard

¹Department of Medicine, University of Florida Shands Cancer Center, Gainesville, Florida 32610-3633, USA.

Cancer Research

|November 1, 2008

Summary

This summary is machine-generated.

Tnk1/Kos1, a protein tyrosine kinase, acts as a tumor suppressor by inhibiting cell growth. Its absence leads to increased Ras activity and a higher incidence of spontaneous tumors in mice.

More Related Videos

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Area of Science:

Molecular Biology
Oncology
Biochemistry

Background:

Tnk1/Kos1 is a non-receptor protein tyrosine kinase.
Its catalytic activity is crucial for negatively regulating cell growth.
Dysregulation of Tnk1/Kos1 is linked to cancer development.

Purpose of the Study:

To investigate the role of Tnk1/Kos1 in tumor suppression.
To elucidate the mechanism by which Tnk1/Kos1 regulates cell growth and Ras activation.

Main Methods:

Generation of Tnk1/Kos1 null mice using homologous recombination.
Analysis of tumor development rates in Tnk1 heterozygous and null mice.
Assessment of Ras activation levels and Ras-guanine exchange factor (GEF) activity in Tnk1-deficient cells.
Investigation of Tnk1/Kos1's direct interaction with Grb2.

Main Results:

Tnk1/Kos1 null mice exhibit high rates of spontaneous lymphomas and carcinomas.
Tnk1/Kos1 expression is silenced in tumors, associated with promoter hypermethylation.
Tnk1/Kos1 deficiency leads to increased basal and EGF-stimulated Ras activation due to elevated Ras-GEF activity.
Tnk1/Kos1 directly phosphorylates Grb2, disrupting the Grb2-Sos1 complex and suppressing Ras activation.

Conclusions:

Tnk1/Kos1 functions as a tumor suppressor by down-regulating Ras activity.
The catalytic activity of Tnk1/Kos1 is essential for its tumor-suppressive function.
Tnk1/Kos1's mechanism involves regulating Ras-guanine exchange factor activity through Grb2 phosphorylation.